Transaction #13367 · Form 4 · 0001878313-25-000045
MAIA Biotechnology, Inc. · Purchase · Common Stock
MAIA Biotechnology, Inc. · Transacted November 25, 2025 · Filed November 26, 2025
What does this filing report?
An SEC Form 4 filing for MAIA Biotechnology, Inc. records a purchase involving Common Stock on November 25, 2025. The reported quantity was 15,000. The filing date is November 26, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- MAIA Biotechnology, Inc.
- Company CIK
- 0001878313
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 15,000
- Reported price
- 0.98 · See footnotes
- Reference value
- 14,700
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 1,349,289
- Ownership description
- See Footnote
- SEC acceptance time
- Nov 26, 2025, 4:43 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Smith Stan ↗
Director
CIK 0001913199
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9675 to $0.9899, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- F2
- These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- F3
- The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9550 to $1.05, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.